Introduction {#sec1}
============

Osteoarthritis (OA) is a degenerative joint disorder resulting in destruction of articular cartilage, osteophyte formation, and subchondral bone sclerosis \[[@B1]\]. OA is a polygenic disease and its pathogenesis is influenced by several environmental factors such as ageing, hormones, mechanical factors, and lifestyle. Genetic factors account for 50% of the risk of OA development \[[@B2]\] and prior research suggests that OA is primarily influenced by genetic risk factors due to common population polymorphisms in multiple genes \[[@B3]\]. Therefore, candidate gene studies may provide insight into OA development.

Angiotensin-converting enzyme (ACE) gene is localized on chromosome 17 and contains a polymorphism based on the presence (insertion, I) or absence (deletion, D) within intron 16, of a 287-bp Alu repeat sequence within intron 16, resulting in three different genotypes: DD and II homozygous and ID heterozygous. Plasma ACE levels vary with polymorphism. The role of ACE polymorphism has been investigated as a risk factor for several diseases such as inflammatory and immune-related disorders \[[@B7]\], particularly the rheumatic and autoimmune diseases.

Several studies have investigated the relationship between OA and the ACE I/D polymorphism \[[@B7]\], but the results were contradictory. As gene pools, lifestyle, and gene--environment interactions vary amongst the populations, the risk shall not be supposed as identical in every population with respect to genotypes. Therefore, we conducted this case--control study to investigate the association between ACE gene I/D polymorphism and knee OA susceptibility in a Chinese Han population. In addition, we performed a meta-analysis together with the present study to verify the relationship between this single nucleotide polymorphism (SNP) and knee OA risk comprehensively.

Materials and methods {#sec2}
=====================

Study population {#sec2-1}
----------------

A hospital-based case--control design was used in the present study. A total of 282 knee OA patients and 316 healthy controls were selected from Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College between February 2014 and May 2017. The diagnosis of knee OA fulfilled the American College of Rheumatology criteria (1987) \[[@B13]\]. Inclusion criteria were: (i) any symptom and/or sign of knee OA, (ii) no evidence for any other form of arthritis, and (iii) informed consent obtained. Participants who had undergone knee surgery, and those with any systemic inflammatory or autoimmune disorder, or any type of malignant or chronic illness were excluded from the present study. Control subjects were consecutively selected amongst people without personal and family history of knee OA and were matched for age (±5 years) and sex. The demographic, lifestyle, and clinical characteristics of all patients and controls, such as age, gender, body mass index (BMI: kg/m^2^), and K-L grade were collected from medical records. This case--control study was approved by the Ethics Committee of Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College and performed according to *Declaration of Helsinki*. All patients provided written informed consent prior to participation.

Genomic DNA extraction and genotyping {#sec2-2}
-------------------------------------

Peripheral blood samples were taken from all patients and controls, and stored in EDTA tubes. DNA was extracted from blood examples using the QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany). The genotypes of ACE gene polymorphism were determined by PCR using primers and conditions described previously \[[@B8],[@B12]\]. The PCR program included the following steps: initial denaturation at 95°C for 5 min; 35 cycles of denaturation at 95°C for 30s, annealing at 58°C for 30 s, and extension at 72°C for 30s and a final extension at 72°C for 10 min. To control the quality of genotyping, two independent investigators interpreted images of each gel, and at least 10% of samples were randomly selected for repeated genotyping.

Statistical analysis {#sec2-3}
--------------------

Hardy--Weinberg equilibrium (HWE) of the SNP genotypes was analyzed by the goodness-of-fit chi-square (χ^2^) test to compare the observed and expected genotype frequencies amongst controls. Association between ACE gene I/D polymorphism and knee OA risk was assessed by logistic regression with odds ratio (OR) and 95% confidence interval (CI). χ^2^ test was used to assess the difference in the demographic characteristics, variables, and the genotypes of the ACE gene I/D polymorphism. Above statistical analyses were performed on SAS software package (ver. 9.1.3; SAS Institute, Cary, NC, U.S.A.) with the significant level at *P*\<0.05. To fully investigate the association of ACE gene I/D polymorphism with knee OA, we also conducted a meta-analysis which was performed using the Stata 11.0 software (StataCorp, College Station, TX, U.S.A.).

Results {#sec3}
=======

Clinical information of the study population {#sec3-1}
--------------------------------------------

The characteristics of the subjects in the case and control groups are summarized in [Table 1](#T1){ref-type="table"}. Cases and controls were well matched in terms of age and gender (*P*=0.593 and *P*=0.328, respectively), and no significant differences in gender and age were observed between the OA patients and controls. A significant association was found in the subgroup of BMI. In addition, disease severity in the knee OA cases and controls was assessed via the Kellgren-Lawrence grade (K-L grade). The controls and cases were concentrated in grade 0--4. Other characteristics of the subjects are presented in [Table 1](#T1){ref-type="table"}.

###### Characteristics of subjects with knee OA and control subjects

  Variable                   Patients (*n*=282)   Controls (*n*=316)   *P*-value
  -------------------------- -------------------- -------------------- -----------
  Age (years)                54.34 ± 4.55         54.62 ± 5.45         0.500
  Number of male/female      75/207               77/239               0.532
  BMI (kg/m^2^)              27.42 ± 3.34         25.00 ± 3.44         \<0.001
  Onset age                  46.48 ± 6.52                              
  Duration of OA             7.56 ± 4.16                               
  ESR, mm/h                  13.65 ± 4.83         14.20 ± 5.00         0.174
  CRP, mg/l                  2.50 ± 0.89          1.66 ± 0.46          \<0.001
  Symptoms of patients                                                 
  Arthralgia                 219 (77.7%)                               
  Arthroncus                 186 (66.0%)                               
  Muscle atrophy             31 (11.0%)                                
  Joint deformity            23 (8.2%)                                 
  Kellgren--Lawrence grade                        ---                  ---
  1                          62 (22.0%)           ---                  ---
  2                          141 (50.0%)          ---                  ---
  3                          65 (23.0%)           ---                  ---
  4                          14 (5.0%)            ---                  ---

Abbreviations: CRP, C-reaction protein; ESR, erythrocyte sedimentation rate.

Association between ACE gene I/D polymorphism and knee OA risk {#sec3-2}
--------------------------------------------------------------

The genotype distributions of ACE gene I/D polymorphism in all subjects are delineated in [Table 2](#T2){ref-type="table"}. Genotype distributions for rs2292832 polymorphism in the controls conformed to the HWE (*P*=0.802). Logistic regression analyses revealed that the DD genotype or D allele carriers of I/D polymorphism was significantly associated with increased risk of knee OA (DD compared with ID+II: adjusted OR = 1.83, 95% CI = 1.15--2.37, *P*=0.007; ID+DD compared with II: adjusted OR = 1.65, 95% CI = 1.15--2.37, *P*=0.007; D compared with I: OR = 1.47, 95% CI = 1.16--1.85, *P*=0.001; [Table 2](#T2){ref-type="table"}). We also conducted stratification analyses of sex, age, and BMI. We obtain significant associations amongst the groups of females, ≥55 years, abnormal BMI ([Table 3](#T3){ref-type="table"}). Furthermore, we investigated the association between ACE I/D polymorphism and clinical features of OA and found DD genotype of this SNP was associated with arthralgia ([Table 4](#T4){ref-type="table"}).

###### Logistic regression analysis of associations between ACE I/D polymorphism and risk of knee OA

  Genotype                 Cases[^1^](#T2TFN1){ref-type="table-fn"} (*n*=282)   Controls[^1^](#T2TFN1){ref-type="table-fn"} (*n*=316)   OR (95% CI)   *P*         Adjusted OR (95% CI)[^2^](#T2TFN2){ref-type="table-fn"}   Adjusted *P*[^2^](#T2TFN2){ref-type="table-fn"}                           
  ------------------------ ---------------------------------------------------- ------------------------------------------------------- ------------- ----------- --------------------------------------------------------- ------------------------------------------------- ----------------------- -------
  II                       39                                                   14.0                                                    67            21.3        1                                                                                                           1.0                     
  ID                       128                                                  45.9                                                    157           49.8        1.40 (0.89, 2.22)                                         0.150                                             1.55 (0.95, 2.54)       0.077
  DD                       112                                                  40.1                                                    91            28.9        **2.11 (1.31, 3.42)**                                     0.002                                             **2.28 (1.37, 3.82)**   0.002
  DD compared with ID+II   112/167                                              40.1/59.9                                               91/224        28.9/71.1   **1.65 (1.17, 2.32)**                                     0.004                                             **1.83 (1.15, 2.90)**   0.011
  ID+DD compared with II   240/39                                               86.0/14.0                                               248/67        79.7/21.3   **1.66 (1.08, 2.56)**                                     0.021                                             **1.65 (1.15, 2.37)**   0.007
  Allele frequency                                                                                                                                                                                                                                                                                    
  I                        206                                                  36.9                                                    291           46.2        1                                                                                                                                   
  D                        352                                                  63.1                                                    339           53.8        **1.47 (1.16, 1.85)**                                     0.001                                                                     

Bold values are statistically significant (*P*\<0.05).

The genotyping was successful in 279 cases and 315 controls.

Adjusted for age, sex, and BMI.

###### Stratified analyses between ACE I/D polymorphisms and the risk of OA

  Variable      Case/control   ID compared with II   DD compared with II   DD compared with ID+II     DD+ID compared with II                                            
  ------------- -------------- --------------------- --------------------- -------------------------- -------------------------------- -------------------------------- ------------------------------
  Sex                                                                                                                                                                   
    Male        13/14          35/34                 26/28                 1.10 (0.46, 2.70); 0.821   1.00 (0.40, 2.52); 1.000         0.93 (0.48, 1.81); 0.828         1.06 (0.46, 2.44); 0.892
    Female      26/53          93/123                86/63                 1.54 (0.90, 2.65); 0.117   **2.78 (1.57, 4.92); \<0.001**   **2.02 (1.35, 3.01); \<0.001**   **1.96 (1.18, 3.27); 0.010**
  Age (years)                                                                                                                                                           
    \<55        18/32          65/76                 61/52                 1.52 (0.78, 2.96); 0.217   **2.09 (1.05, 4.14); 0.036**     1.53 (0.96, 2.43); 0.076         1.75 (0.93, 3.29); 0.081
    ≥55         21/35          63/81                 51/39                 1.30 (0.69, 2.44); 0.422   **2.18 (1.10, 4.31); 0.025**     **1.81 (1.09, 2.99); 0.021**     1.58 (0.87, 2.88); 0.133
  BMI                                                                                                                                                                   
    Normal      5/22           17/55                 14/34                 1.36 (0.45, 4.14); 0.588   1.81 (0.57, 5.74); 0.313         1.44 (0.66, 3.15); 0.360         1.53 (0.53, 4.40); 0.427
    Abnormal    34/45          111/102               98/57                 1.44 (0.86, 2.42); 0.169   **2.28 (1.31, 3.95); 0.004**     **1.74 (1.17, 2.60); 0.006**     **1.74 (1.06, 2.84); 0.027**

Bold values are statistically significant (*P*\<0.05).

###### The association between ACE I/D polymorphism and clinical features of OA

  Variables         Genotype   Heterozygote   Homozygote   Dominant                    Recessive                                                  
  ----------------- ---------- -------------- ------------ --------------------------- ------------------------------ --------------------------- --------------------------
  Onset age                                                                                                                                       
  ≤52               89         101            31           1.0                                                                                    
  \>52              23         27             8            1.04 (0.43, 2.51); 0.938    1.00 (0.41, 2.47); 0.998       1.02 (0.44, 2.36); 0.964    0.98 (0.54, 1.76); 0.932
  Arthralgia                                                                                                                                      
  \-                23         30             15           1.0                                                                                    
  \+                89         98             24           1.82 (0.78, 4.21); 0.161    **2.43 (1.02, 5.78); 0.042**   2.07 (0.94, 4.60); 0.068    1.52 (0.85, 2.72); 0.158
  Arthroncus                                                                                                                                      
  \-                41         41             14           1.0                                                                                    
  \+                71         87             25           1.19 (0.56, 2.52); 0.653    0.97 (0.45, 2.07); 0.937       1.08 (0.53, 2.19); 0.833    0.85 (0.52, 1.41); 0.527
  Muscle atrophy                                                                                                                                  
  \-                99         111            38           1.0                                                                                    
  \+                13         17             1            5.82 (0.75, 45.22); 0.059   5.00 (0.63, 39.47); 0.094      5.43 (0.72, 41.01); 0.067   1.09 (0.51, 2.32); 0.829
  Joint deformity                                                                                                                                 
  \-                101        118            37           1.0                                                                                    
  \+                11         10             2            1.57 (0.33, 7.48); 0.570    2.02 (0.43, 9.52); 0.368       1.77 (0.40, 7.88); 0.446    1.41 (0.60, 3.31); 0.433
  K-L grade                                                                                                                                       
  1--2              84         92             26           1.0                                                                                    
  3--4              28         36             13           0.78 (0.36, 1.69); 0.532    0.67 (0.30, 1.47); 0.314       0.82 (0.40,1.70); 0.593     1.25 (0.72, 2.14); 0.427

Bold values are statistically significant (*P*\<0.05).

Results of false-positive report probability analysis for significant findings {#sec3-3}
------------------------------------------------------------------------------

We preset 0.2 as the false-positive report probability (FPRP) threshold. As shown in [Table 5](#T5){ref-type="table"}, at the prior probability of 0.1, the significant findings for the ACE I/D polymorphism remained unstable in the allele, dominant, homozygote, and heterozygote models. Moreover, the same effects were also seen in the stratification analyses of population-based control (PB), HWE-positive, and Asian groups.

###### FPRP values for associations between the ACE I/D polymorphism and OA risk

  Variables                OR (95% CI)             *P*-value     Power       Prior probability                                             
  ------------------------ ----------------------- ------------- ----------- ------------------- ------------- ------------- ------------- -----------
  D vs. I                  **1.38 (1.03, 1.86)**   0.034         0.708       0.229               0.471         0.908         0.990         0.999
  Caucasian                **2.12 (1.67, 2.68)**   **\<0.001**   **0.622**   **\<0.001**         **\<0.001**   **0.002**     **0.015**     0.133
  PB                       **1.52 (1.02, 2.27)**   0.041         0.474       0.355               0.622         0.948         0.995         0.999
  Unclear OA               **2.12 (1.67, 2.68)**   **\<0.001**   **0.622**   **\<0.001**         **\<0.001**   **0.002**     **0.015**     0.133
  DD+ID compared with II   **1.70 (1.11, 2.60)**   0.014         0.500       0.285               0.545         0.929         0.993         0.999
  Caucasian                **3.84 (2.17, 6.78)**   **\<0.001**   **0.500**   **0.001**           **0.003**     **0.028**     0.222         0.741
  PB                       **1.98 (1.10, 3.54)**   0.021         0.500       0.125               0.300         0.825         0.979         0.998
  Unclear OA               **3.84 (2.17, 6.78)**   **\<0.001**   **0.500**   **\<0.001**         **\<0.001**   **0.001**     **0.007**     0.067
  DD compared with ID+II                                                                                                                   
  Caucasian                **1.84 (1.20, 2.84)**   0.006         0.500       0.037               0.103         0.559         0.927         0.992
  Unclear OA               **1.91 (1.34, 2.72)**   \<0.001       0.500       0.003               0.008         0.082         0.473         0.900
  DD compared with II      **1.84 (1.02, 3.30)**   \<0.001       0.418       0.041               0.206         0.438         0.896         0.989
  Caucasian                **4.32 (2.48, 7.54)**   **\<0.001**   **0.500**   **\<0.001**         **\<0.001**   **\<0.001**   **0.001**     0.005
  Unclear OA               **4.32 (2.48, 7.54)**   **\<0.001**   **0.500**   **\<0.001**         **\<0.001**   **\<0.001**   **0.001**     0.005
  HWE-negative             0.44 (0.21, 0.92)       0.029         0.500       0.127               0.304         0.828         0.980         0.998
  Other methods            3.40 (1.36, 8.47)       0.009         0.500       0.052               0.140         0.642         0.948         0.995
  ID compared with II      **1.59 (1.11, 2.27)**   0.011         0.500       0.079               0.204         0.739         0.966         0.997
  Asian                    **1.26 (1.02, 1.55)**   0.028         0.500       0.211               0.445         0.898         0.989         0.999
  Caucasian                **3.26 (2.11, 5.06)**   **\<0.001**   **0.500**   **\<0.001**         **\<0.001**   **\<0.001**   **\<0.001**   **0.003**
  HWE-positive             **1.26 (1.02, 1.55)**   0.028         0.500       0.211               0.445         0.898         0.989         0.999
  HWE-negative             **2.46 (1.10, 5.49)**   0.028         0.500       0.150               0.346         0.853         0.983         0.999
  PB                       **1.79 (1.09, 2.92)**   0.020         0.500       0.124               0.298         0.824         0.979         0.998
  Knee OA                  **1.24 (1.01, 1.52)**   0.038         0.500       0.234               0.479         0.910         0.990         0.999
  Unclear OA               **3.26 (2.11, 5.06)**   **\<0.001**   **0.500**   **\<0.001**         **\<0.001**   **\<0.001**   **\<0.001**   **0.003**

General characteristics of included studies and quantitative analysis of this meta-analysis {#sec3-4}
-------------------------------------------------------------------------------------------

[Table 6](#T6){ref-type="table"} lists the characteristics of included studies exploring the associations between ACE gene I/D polymorphism and knee OA. Four Asian studies (including the present study), two Caucasian studies, and one Arabian study were identified in this meta-analysis. The Newcastle--Ottawa Scales (NOS) scores of all included studies ranged from 5 to 6 stars, suggesting that they were studies of high methodological quality.

###### Characteristics of included studies

  Author and year     Age             Sex (male/female)   SOC       Country   Ethnicity   OA TYPE   Case/ control   Genotyping method   HWE       NOS                      
  ------------------- --------------- ------------------- --------- --------- ----------- --------- --------------- ------------------- --------- -------------- --------- ---
  Hong, 2003          58.6 ± 9.4      N/A                 48/94     N/A       PB          Korea     Asian           Knee OA             142/135   PCR            0.117     6
  Shehab, 2008        57.07 ± 9.15    N/A                 13/102    N/A       HB          Kuwait    Arabian         Knee OA             115/111   PCR            \<0.001   5
  Bayram, 2010        54.16 ± 1.20    44.6 ± 2.00         38/102    17/43     PB          Turkey    Caucasian       Unclear OA          140/60    PCR            0.013     5
  Inair, 2013         58.04 ± 10.87   53.03 ± 12.88       60/161    65/135    PB          Turkey    Caucasian       Unclear OA          221/200   PCR            0.003     6
  Poornima, 2014      42.41 ± 8.11    42.17 ± 7.98        32/68     31/69     PB          India     Asian           Knee OA             100/100   PCR            0.480     5
  Lin, 2016           74.9 ± 7.1      73.3 ± 6.6          194/253   206/217   PB          Taiwan    Asian           Knee OA             447/423   PCR            0.945     6
  The present study   54.34 ± 4.55    54.62 ± 5.45        75/207    77/239    HB          China     Asian           Knee OA             282/316   MALDI-TOF-MS   0.963     6

Abbreviations: HB, hospital-based control; SOC, source of control.

Our meta-analysis indicated that ACE gene I/D polymorphism was associated with the increased risk for knee OA (D compared with I: OR = 1.39, 95% CI = 1.03--1.86, *P*=0.031; DD+ID compared with II: OR = 1.70, 95% CI = 1.11--2.60, *P*=0.016; DD compared with II: OR = 1.84, 95% CI = 1.02--3.30, *P*=0.041; ID compared with II: OR = 1.59, 95% CI = 1.11--2.27, *P*=0.010; [Table 7](#T7){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}). In the subgroup analysis of ethnicity, we found that this SNP increased OA risk amongst Asian and Caucasian populations ([Table 7](#T7){ref-type="table"} and [Figure 2](#F2){ref-type="fig"}). Stratification analysis by types of OA indicated that ACE gene I/D polymorphism increased the risk of knee OA and unclear OA ([Table 7](#T7){ref-type="table"} and [Figure 3](#F3){ref-type="fig"}). We also observed positive results in the Chinese groups. We did not obtain any different conclusions after eliminating the studies which did not meet the HWE, indicating that the data of this meta-analysis were trustworthy and stable.

![Forest plot shows OR for the associations between ACE gene I/D polymorphism and OA risk (D compared with I)](bsr-39-bsr20181713-g1){#F1}

![Stratification analysis by ethnicity shows OR for the association between ACE gene I/D polymorphism and OA risk (D compared with I)](bsr-39-bsr20181713-g2){#F2}

![Stratification analysis by type of OA shows OR for the association between ACE gene I/D polymorphism and OA risk (DD+ID compared with II)](bsr-39-bsr20181713-g3){#F3}

###### Meta-analysis of association between ACE I/D polymorphism and the risk of knee OA

  Comparison               Category      Category       Studies   OR (95% CI)             *P*-value   *P* for heterogeneity
  ------------------------ ------------- -------------- --------- ----------------------- ----------- -----------------------
  D compared with I        Total                        7         **1.38 (1.03, 1.86)**   0.031       \<0.001
                           Ethnicity     Asian          4         1.26 (0.91, 1.75)       0.171       \<0.001
                                         Arabian        1         0.80 (0.53, 1.22)       0.302       N/A
                                         Caucasian      2         **2.12 (1.67, 2.68)**   \<0.001     0.484
                           Population    Non-Chinese    5         1.45 (0.90, 2.33)       0.128       \<0.001
                                         Chinese        2         1.26 (0.94, 1.68)       0.122       0.057
                           HWE           HWE-positive   4         1.26 (0.91, 1.75)       0.171       0.001
                                         HWE-negative   3         1.58 (0.85, 2.95)       0.148       \<0.001
                           SOC           PB             5         **1.52 (1.02, 2.27)**   0.042       0.180
                                         HB             2         1.11 (0.62, 2.00)       0.719       0.152
                           Types of OA   Knee OA        5         1.16 (0.86, 1.57)       0.321       0.091
                                         Unclear OA     2         **2.12 (1.67, 2.68)**   \<0.001     \<0.001
  DD+ID compared with II   Total                        7         **1.70 (1.11, 2.60)**   0.016       \<0.001
                           Ethnicity     Asian          4         1.33 (0.97, 1.83)       0.078       0.097
                                         Arabian        1         0.83 (0.42, 1.62)       0.578       N/A
                                         Caucasian      2         **3.84 (2.17, 6.78)**   \<0.001     0.223
                           Population    Non-Chinese    5         1.90 (0.94, 3.82)       0.073       \<0.001
                                         Chinese        2         1.32 (1.05, 1.66)       0.016       0.220
                           HWE           HWE-positive   4         1.33 (0.97, 1.83)       0.078       0.097
                                         HWE-negative   3         2.45 (0.86, 6.93)       0.093       0.001
                           SOC           PB             5         **1.98 (1.10, 3.54)**   0.022       0.359
                                         HB             2         1.23 (0.63, 2.43)       0.548       0.161
                           Types of OA   Knee OA        5         1.25 (0.93, 1.68)       0.141       0.054
                                         Unclear OA     2         **3.84 (2.17,6.78)**    \<0.001     0.066
  DD compared with ID+II   Total                        7         1.34 (0.92, 1.94)       0.130       \<0.001
                           Ethnicity     Asian          4         1.27 (0.72, 2.22)       0.408       0.001
                                         Arabian        1         0.78 (0.45, 1.34)       0.365       N/A
                                         Caucasian      2         **1.84 (1.20, 2.84)**   \<0.001     0.771
                           Population    Non-Chinese    5         1.37 (0.79, 2.4)        0.264       \<0.001
                                         Chinese        2         1.26 (0.73, 2.19)       0.407       0.041
                           HWE           HWE-positive   4         1.27 (0.72, 2.22)       0.408       0.001
                                         HWE-negative   3         1.43 (0.80, 2.58)       0.228       0.024
                           SOC           PB             5         1.42 (0.85, 2.36)       0.184       0.267
                                         HB             2         1.17 (0.56, 2.44)       0.677       0.230
                           Types of OA   Knee OA        5         1.15 (0.71, 1.86)       0.562       0.233
                                         Unclear OA     2         **1.91 (1.34, 2.72)**   \<0.001     \<0.001
  DD compared with II      Total                        7         **1.84 (1.02, 3.30)**   0.041       \<0.001
                           Ethnicity     Asian          4         1.45 (0.75, 2.82)       0.268       0.001
                                         Arabian        1         0.78 (0.39, 1.56)       0.484       N/A
                                         Caucasian      2         **4.32 (2.48, 7.54)**   \<0.001     0.265
                           Population    Non-Chinese    5         2.05 (0.84, 5.02)       0.117       \<0.001
                                         Chinese        2         1.49 (0.75, 2.93)       0.253       0.039
                           HWE           HWE-positive   4         1.45 (0.75, 2.82)       0.268       0.001
                                         HWE-negative   3         2.60 (0.79, 8.55)       0.115       \<0.001
                           SOC           PB             5         2.14 (0.95, 4.83)       0.066       0.737
                                         HB             2         1.33 (0.50, 3.51)       0.569       0.403
                           Types of OA   Knee OA        5         1.29 (0.73, 2.28)       0.377       0.322
                                         Unclear OA     2         **4.32 (2.48, 7.54)**   \<0.001     0.038
  ID compared with II      Total                        7         **1.59 (1.11, 2.27)**   0.010       0.007
                           Ethnicity     Asian          4         **1.26 (1.02, 1.55)**   0.034       0.794
                                         Arabian        1         1.01 (0.42, 2.41)       0.983       N/A
                                         Caucasian      2         **3.26 (2.11, 5.06)**   \<0.001     0.326
                           Population    Non-Chinese    5         **1.81 (1.01, 3.23)**   0.046       0.006
                                         Chinese        2         **1.29 (1.01, 1.64)**   0.040       0.673
                           HWE           HWE-positive   4         **1.26 (1.02, 1.55)**   0.034       0.794
                                         HWE-negative   3         **2.46 (1.10, 5.49)**   0.028       0.038
                           SOC           PB             5         **1.79 (1.09, 2.92)**   0.021       0.229
                                         HB             2         1.30 (1.12, 2.27)       0.199       \<0.001
                           Types of OA   Knee OA        5         **1.24 (1.01, 1.52)**   0.039       \<0.001
                                         Unclear OA     2         **3.26 (2.11, 5.06)**   \<0.001     \<0.001

Abbreviations: HB, hospital-based control; SOC, source of control.

Discussion {#sec4}
==========

The present case--control study showed that the DD genotype or D carriers of I/D polymorphism was associated with significantly increased risk of knee OA in a Chinese Han population. Additionally, the present study obtained significant associations amongst the groups of females, ≥55 years, and abnormal BMI. Furthermore, the study found DD genotype of I/D polymorphism was associated with arthralgia. Using meta-analysis, we also found that ACE gene I/D polymorphism was associated with increased risk of OA. Similar results were replicated in the stratification analyses of ethnicity, HWE, SOC, and types of OA. In conclusion, this case--control study and meta-analysis found that ACE gene I/D polymorphism is associated with increased risk for knee OA.

In previous studies, ACE gene was found associated with rheumatic and autoimmune diseases. OA is an inflammatory disorder, which is associated with these proinflammatory cytokines \[[@B14]\]. Angiotensin II played a vital role in OA progression by modulating the synthesis of proinflammatory cytokines including tumor necrosis factor-alpha (TNF-α), CCL2 (C-C motif chemokine ligand 2), and IL-6 (Interleukin-6) \[[@B15]\]. Notably, levels of ACE in synovial fluid were significantly higher than control groups \[[@B16]\] in OA patients. Studies have demonstrated that the presence of D allele of I/D polymorphism is associated with higher levels of plasma ACE \[[@B17]\].

Several studies investigated the association between ACE gene I/D polymorphism and OA risk. Hong et al. \[[@B7]\] found ACE I/D polymorphism was a risk factor for early-onset knee OA in a Korean study. They indicated that I allele was associated with the radiographically severe and functionally poor OA \[[@B7]\]. In a subsequent study from Kuwait, Shehab et al. \[[@B12]\] revealed that there was no significant difference in the distribution of genotype or allele frequency between control subjects and OA groups. In addition, they did not find an association between any genotypes of I/D and clinical severity of OA \[[@B12]\]. Shehab et al. \[[@B12]\] showed a very high incidence of D-allele in Kuwaiti Arabs, while the Korean study \[[@B7]\] indicated the frequency of I-allele was significantly higher in early onset OA. The distinct distribution of allele frequency may explain the different findings of abovementioned two studies \[[@B7],[@B12]\]. Poornima et al. \[[@B11]\] observed that I/D polymorphism was associated with increased risk of OA in an Indian population. Similar results were also obtained in two Turkish studies \[[@B8],[@B9]\]. They \[[@B8],[@B9]\] both suggested that DD genotype of the ACE gene I/D polymorphism increased the risk of knee OA in Turkish populations. Due to the conflicting findings, Lin et al. \[[@B10]\] conducted a case--control study and meta-analysis to validate the association of I/D polymorphism with OA risk. They did not find any significant association between I/D polymorphism and knee OA in the case--control study and meta-analysis \[[@B10]\]. It was noteworthy that they regarded the Turkish populations as Arabians. We thought that the Turkish populations should be divided into Caucasians. Moreover, the meta-analysis by Lin et al. \[[@B10]\] actually found a significant difference in the dominant model \[OR: 1.72 (95% CI: 1.02 ± 2.90)\], indicating that DD/ID genotype carriers had an increased risk for OA \[[@B10]\]. However, Lin et al. \[[@B10]\] regarded it as negative finding. Two previous meta-analyses investigated the association between this SNP and OA risk. Ai et al. \[[@B18]\] only found I/D polymorphism was associated with increased risk for Caucasians, but not in overall populations and Asians. In another meta-analysis, Shang et al. \[[@B19]\] suggested that ID genotype was weakly associated with OA risk. This meta-analysis (total 1447 cases and 1345 controls) indicated that ACE gene I/D polymorphism was associated with the increased risk of OA.

In the subgroup analysis of ethnicity, we found that ACE gene I/D polymorphism increased OA risk amongst Asian and Caucasian populations. However, no significant associations were obtained in the meta-analysis by Lin et al. \[[@B10]\]. In the meta-analysis of Ai et al. \[[@B18]\], they showed significant association only amongst Caucasians, which was different from that of this meta-analysis. This meta-analysis found that SNP was associated with increased risk for overall populations, including Caucasians and Asians. We also conducted the stratification analysis of types of OA, indicating that ACE gene I/D polymorphism increased the knee OA and unclear OA. In addition, we did not obtain any different conclusions after eliminating the studies which did not meet the HWE. Sensitivity analysis indicated that our results were more robust and stable. Furthermore, we performed stratification analyses of sex, age, and BMI, and found significant associations amongst the groups of females, ≥55 years, abnormal BMI, indicating that these exposure factors may play an important role in the interaction between this SNP and OA. We further made analysis between ACE I/D polymorphism and some clinical features of OA and found DD genotype of this SNP was associated with arthralgia.

Several potential limitations of this case--control study and meta-analysis should be considered. First, we cannot conduct the subgroups of some confounding factors due to the lack of corresponding data. Second, our results were based on unadjusted estimates for confounding factors. Third, the sample size of the present study was not large enough, which might make our work underpowered. Fourth, the sample sizes of Caucasians and Arabians were not large enough in this meta-analysis. Fifth, included studies were only involved in Asians, Caucasians, and Arabians, and studies amongst other racial groups are urgently needed. Sixth, the present study only focussed on one gene. Seventh, the present study with limited sample sizes could not provide sufficient evidence to draw a certain conclusion. Finally, we cannot conclude that I/D polymorphisms are susceptibility loci for other types of OA, highlighting the necessity for the further investigation of more types of OA.

In conclusion, this case--control study and meta-analysis found that ACE gene I/D polymorphism is associated with increased risk for knee OA. Further multi-center, well-designed studies with larger sample sizes that include gene--environment interactions assessment are warranted to confirm our findings.
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ACE

:   angiotensin-converting enzyme

BMI

:   body mass index

CCL2

:   C-C motif chemokine ligand 2

CI

:   confidence interval

D

:   deletion

HWE

:   Hardy--Weinberg equilibrium

I
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IL-6

:   Interleukin-6

K-L grade

:   Kellgren-Lawrence grade

OA

:   osteoarthritis

OR

:   odds ratio
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:   population-based control

SNP

:   single nucleotide polymorphism

TNF-α

:   tumor necrosis factor-alpha
